Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy.

Guerrot D, Dussaule JC, Mael-Ainin M, Xu-Dubois YC, Rondeau E, Chatziantoniou C, Placier S.

PLoS One. 2012;7(3):e31974. doi: 10.1371/journal.pone.0031974.

2.

Left ventricular periostin gene expression is associated with fibrogenesis in experimental renal insufficiency.

Pohjolainen V, Rysä J, Näpänkangas J, Kööbi P, Eräranta A, Ilves M, Serpi R, Pörsti I, Ruskoaho H.

Nephrol Dial Transplant. 2012 Jan;27(1):115-22. doi: 10.1093/ndt/gfr279.

PMID:
21712488
3.

Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.

Helle F, Jouzel C, Chadjichristos C, Placier S, Flamant M, Guerrot D, François H, Dussaule JC, Chatziantoniou C.

Am J Physiol Renal Physiol. 2009 Jul;297(1):F191-9. doi: 10.1152/ajprenal.00015.2009.

4.

Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells.

Satirapoj B, Wang Y, Chamberlin MP, Dai T, LaPage J, Phillips L, Nast CC, Adler SG.

Nephrol Dial Transplant. 2012 Jul;27(7):2702-11. doi: 10.1093/ndt/gfr670.

5.

Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.

Helle F, Iversen BM, Chatziantoniou C.

Am J Physiol Renal Physiol. 2010 May;298(5):F1170-7. doi: 10.1152/ajprenal.00056.2009.

7.

Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats.

de Gracia MC, Osuna A, O'Valle F, del Moral RG, Wangensteen R, del Rio CG, Vargas F.

J Am Soc Nephrol. 2000 Nov;11(11):1995-2000.

8.

Effects of losartan on blood pressure, oxidative stress, and nitrate/nitrite levels in the nitric oxide deficient hypertensive rats.

Khattab M, Ahmad M, Al-Shabanah OA, Raza M.

Receptors Channels. 2004;10(5-6):147-57.

PMID:
15989079
9.

Nitric oxide modulates the development and surgical reversal of renovascular hypertension in rats.

Huang WC, Tsai RY, Fang TC.

J Hypertens. 2000 May;18(5):601-13.

PMID:
10826564
10.
11.

Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II.

D'Amours M, Lebel M, Grose JH, Larivière R.

Can J Physiol Pharmacol. 1999 Jan;77(1):8-16.

PMID:
10535660
12.

Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases.

Boffa JJ, Lu Y, Placier S, Stefanski A, Dussaule JC, Chatziantoniou C.

J Am Soc Nephrol. 2003 May;14(5):1132-44.

13.

Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats.

Tharaux PL, Chatziantoniou C, Casellas D, Fouassier L, Ardaillou R, Dussaule JC.

Circulation. 1999 Apr 27;99(16):2185-91.

14.

Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.

François H, Placier S, Flamant M, Tharaux PL, Chansel D, Dussaule JC, Chatziantoniou C.

FASEB J. 2004 May;18(7):926-8.

PMID:
15033924
15.
16.

Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.

Jovanovic D, Jovovic D, Mihailovic-Stanojevic N, Miloradovic Z, Naumovic R, Dimitrijevic J, Maksic N, Djukanovic L.

Biomed Pharmacother. 2009 Sep;63(8):571-6. doi: 10.1016/j.biopha.2008.10.006.

PMID:
19013753
17.

Enhanced expression of serum and glucocorticoid-inducible kinase-1 in kidneys of L-NAME-treated rats.

Feng Y, Wang Y, Xiong J, Liu Z, Yard B, Lang F.

Kidney Blood Press Res. 2006;29(2):94-9.

18.

Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism.

De Gennaro Colonna V, Fioretti S, Rigamonti A, Bonomo S, Manfredi B, Muller EE, Berti F, Rossoni G.

J Hypertens. 2006 Jan;24(1):95-102.

PMID:
16331106
19.

Nitric oxide modulates vascular disease in the remnant kidney model.

Kang DH, Nakagawa T, Feng L, Johnson RJ.

Am J Pathol. 2002 Jul;161(1):239-48.

20.

Effect of nitric oxide inhibition on kidney function in experimental renovascular hypertension.

Dedeoglu IO, Springate JE.

Clin Exp Hypertens. 2001 Apr;23(3):267-75.

PMID:
11339692

Supplemental Content

Support Center